Erdafitinib versus pembrolizumab in pretreated patients with advanced or metastatic urothelial cancer with select FGFR alterations: cohort 2 of the randomized phase III THOR trial

Autor: Bastick, Patricia, Sewak, Sanjeev, Tran, Ben, Pichler, Martin, Shariat, Shahrokh, Rottey, Sylvie, Schatteman, Peter, Schrijvers, Dirk, Verschaeve, Vincent, Vulsteke, Christof, Barros Leite Ferreira, Luiza Aleixo, de Santana Gomes Andrea Juliana, Pereira, Junior, Joao Antonio, Azevedo, Sergio, Bastos, Diogo, Borges, Giuliano, Dettino, Aldo, Antonio, Pires Luis, Luz, Murilo, Martins, Suelen, Mota, Jose Mauricio, Toledo, Joseane, Eigl, Bernhard, Finch, Daygen, Gingerich, Joel, Dong, Haiying, Huang, Jian, Jin, Jie, Pan, Hongming, Sun, Zhongquan, Tian, Ye, Wan, Ben, Wu, Bin, Xu, Ting, Xue, Wei, Zhou, Fangjian, Barthelemy, Philippe, Borchiellini, Delphine, Calcagno, Fabien, Carnot, Aurelien, Cornillon, Pierre, Delva, Remy, Emambux, Sheik, Houede, Nadine, Laguerre, Brigitte, Lauridant, Géraldine, Loriot, Yohann, Mahammedi, Hakim, Maillet, Denis, Pouessel, Damien, Roubaud, Guilhem, Schlurmann-Constans, Friederike, Tosi, Diego, Zanetta, Sylvie, Banek, Severine, Feyerabend, Susan, Kramer, Mario, Niegisch, Guenther, Nuhn, Philipp, Schnabel, Marco, Wuelfing, Christian, Baka, Sofia, Bamias, Aristotelis, Fountzilas, George, Kalofonos, Harabolos, Karalis, Konstantinos, Kotsakis, Athanasios, Timotheadou, Eleni, Landherr, Laszlo, Mangel, Laszlo, Pe’er, Avivit, Levratovsky, Meital, Basso, Umberto, Battelli, Nicola, Cavo, Alessia, De Giorgi, Ugo, Doni, Laura, Galli, Luca, Gigante, Maria Olga, Guadalupi, Valentina, Maio, Michele, Milesi, Laura, Nolè, Franco, Scagliotti, Giorgio, Tortora, Giampaolo, Fukasawa, Satoshi, Harabayashi, Toru, Kamiya, Naoto, Kawahara, Takashi, Kawakita, Mutsushi, Matsubara, Nobunaki, Matsumoto, Kazumasa, Nishimura, Kazuo, Rikiya, Taoka, Shimizu, Nobuaki, Tagaki, Toshio, Kang, Taek Won, Kim, Jwa Hoon, Kim, SeHyun, Lee, Hyo Jin, Lee, Yun-Gyoo, Rha, Sun Young, Seo, Ho Kyung, Los, Maartje, Zurawski, Bogdan, Cortes, Paulo, Faustino, Catia, Vau, Nuno Sineiro, da Luz, Ricardo, Atduev, Vagif, Kirtbaya, Dmitry, Kopyltsov, Evgeny, Lykov, Aleksandr, Marat, Urmantsev, Orlov, Sergey, Penkov, Konstantin, Pirmagomedov, Albert, Semenov, Andrey, Varlamov, Sergey, Anguera, Georgia, Domenech, Montserrat, Girones, Regina, Gonzalez del Alba, Aranzazu, Milagro, Nuria Lainez, Luque, Raquel, Ortega, Esther Martínez, Mellado, Begoña, Méndez Vidal, María Jose, Fernandez, Esteban Nogales, Valderrama, Begoña Perez, Marín, Alvaro Pinto, Santander, Carmen, Huang, Yi-Hsiu, Su, Wen-Pin, Wu, Hung-Chan, Wu, WenJeng, Yu, Kai-Jie, Bilici, Ahmet, Goker, Erdem, Gumus, Mahmut, Karaoglu, Aziz, Kefeli, Umut, Köse, Fatih, Ozguroglu, Mustafa, Tural, Deniz, Turk, Haci, Yalcin, Suayib, Bondarenko, Igor, Khareba, Gennadii, Kidik, Yana, Lychkovskyy, Oleksandr, Sakalo, Valerii, Shevnia, Serghii, Stakhovskyy, Eduard, Bahl, Amit, Crabb, Simon, Powles, Thomas, Sankey, Peter, Sarwar, Mohammad, Benedetto, Pasquale, Burgess, Earle, Dawson, Nancy, Doshi, Gurjyot, Fleming, Mark, Maly, Joseph, Parikh, Mamta, Waterhouse, David, Siefker-Radtke, A.O. ^{1, ∗}, Matsubara, N. ², Park, S.H. ³, Huddart, R.A. ⁴, Burgess, E.F. ⁵, Özgüroğlu, M. ⁶, Valderrama, B.P. ⁷, Laguerre, B. ⁸, Basso, U. ⁹, Triantos, S. ¹⁰, Akapame, S. ¹⁰, Kean, Y. ¹⁰, Deprince, K. ¹¹, Mukhopadhyay, S. ¹², Loriot, Y. ¹³

Publikováno v: In Annals of Oncology January 2024 35(1):107-117

Comparison of three doses of estradiol benzoate for synchronization of follicular wave emergence in suckled

Autor: Amanda Guimarães, Silva, Leonardo Marin Ferreira, Pinto, Nadark de Amorim, Silva, Ana Clara Degan, Mattos, Pablo Henrique, Ambrósio, Keila Maria Roncato, Duarte, Rafael Herrera, Alvarez, Guilherme, Pugliesi

Publikováno v: Animal Reproduction

We aimed to compare the effect of three estradiol benzoate (EB) doses on follicular wave emergence (FWE) and dominant follicle growth of suckled Nelore cows submitted to TAI (D0). On a random day of estrous cycle (D−10), multiparous (MULT; n=36) an

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::af0be87216c65f1de27112929ed64c70
https://pubmed.ncbi.nlm.nih.gov/34691264

1187PD - Phase II study of lenvatinib plus pembrolizumab for disease progression after PD-1/PD-L1 immune checkpoint inhibitor in metastatic clear cell renal cell carcinoma (mccRCC): Results of an interim analysis

Autor: Lee, C.-H. ¹, Shah, A.Y. ², Makker, V. ³, Taylor, M.H. ⁴, Shaffer, D. ⁵, Hsieh, J.J. ⁶, Cohn, A.L. ⁷, DiSimone, C. ⁸, Marin, A Pinto ⁹, Rasco, D.W. ¹⁰, Ribe, S.G. ¹¹, Richards, D.A. ¹², Stepan, D.E. ¹³, Dutcus, C.E. ¹⁴, Wu, J. ¹⁵, Schmidt, E.V. ¹⁶, Perini, R.F. ¹⁷, Motzer, R.J. ³

Publikováno v: In Annals of Oncology October 2019 30 Supplement 5:v483-v484

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

2623 Prospective validation of prognostic classifications in patients (pt) progressing to first-line chemotherapy in metastatic transitional-cell carcinoma (mTCC)

Autor: Arija, J.A. Arranz, Vazquez-Estevez, S., Perez-Valderrama, B., del Muro, X. Garcia, Laínez Milagro, N., Sala, N., Fita, M.J. Juan, Noguerón, E., Sáez, M.I., Rey, P. Maroto, Font, A., Díaz, E. Gallardo, Méndez-Vidal, M.J., Criado, M.P. Lopez, Quintela, M. Lázaro, Marin, A. Pinto, del Alba, A. Gonzalez, Caro, R. Luque, Lobera, C. Santander, Martínez, I. Duran

Publikováno v: In European Journal of Cancer September 2015 51 Supplement 3:S520-S520